Kimberlee C. Drapkin - 11 Jun 2025 Form 4 Insider Report for LENZ Therapeutics, Inc. (LENZ)

Role
Director
Signature
/s/ Daniel R. Chevallard, as Attorney-in-Fact
Issuer symbol
LENZ
Transactions as of
11 Jun 2025
Net transactions value
$0
Form type
4
Filing time
11 Jun 2025, 17:46:36 UTC
Previous filing
05 Jun 2025
Next filing
25 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Drapkin Kimberlee C Director C/O LENZ THERAPEUTICS, INC., 201 LOMAS SANTA FE, SUITE 300, SOLANA BEACH /s/ Daniel R. Chevallard, as Attorney-in-Fact 11 Jun 2025 0001340881

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LENZ Stock Option (right to buy) Award $0 +13,500 $0.000000 13,500 11 Jun 2025 Common Stock 13,500 $30.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's Outside Director Compensation Policy) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on June 11, 2026.

Remarks:

Exhibit 24 - Power of Attorney